SPHK1 and colorectal cancer: Indeed, these studies indicated that SPHK1 inhibition enhances colorectal cancer cell sensitivity to TRAIL (tumour necrosis factor-related apoptosis-inducing ligand)-induced apoptosis, possibly through S1PR1-mediated STAT3 activation and subsequent changes in expression of the TRAIL decoy receptor 1 and death receptor 5.